Last 12 months
Inside the activity.
0 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 30, 2018 Filed Sep 4, 2018 20:51 UTC |
Bodor RobertVP/General Manager-Americas
|
SaleCommon Stock | 4,435 | $150.20 | $666,127.24 |
DisclosureSEC source: 0001437749-18-016526 · rdgdoc.xml · nonDerivative · entry 3 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,755 F2 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2018. F3 · price: Reflects the weighted average price of 4,435 shares of common stock of Proto Labs, Inc. sold by the reporting person on August 30, 2018 with sale prices ranging from $150.00 to $150.70 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 30, 2018 Filed Sep 4, 2018 20:51 UTC |
Bodor RobertVP/General Manager-Americas
|
Exercise / conversionCommon Stock | 907 | $58.35 | $52,923.45 |
DisclosureSEC source: 0001437749-18-016526 · rdgdoc.xml · nonDerivative · entry 2 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2018. Read SEC document |
| August 30, 2018 Filed Sep 4, 2018 20:51 UTC |
Bodor RobertVP/General Manager-Americas
|
Exercise / conversionCommon Stock | 3,528 | $78.59 | $277,265.52 |
DisclosureSEC source: 0001437749-18-016526 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,283 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2018. Read SEC document |
| August 24, 2018 Filed Aug 28, 2018 20:23 UTC |
WAY JOHNChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,912 | $0.00 Strike: $62.90 | $0.00 |
DisclosureSEC source: 0001437749-18-016252 · rdgdoc.xml · derivative · entry 4 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,608 Underlying: Common Stock · 3,912 shares Expires 2024-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on December 1, 2015. Read SEC document |
| August 24, 2018 Filed Aug 28, 2018 20:23 UTC |
WAY JOHNChief Financial Officer
|
SaleCommon Stock | 1,486 | $146.25 | $217,332.11 |
DisclosureSEC source: 0001437749-18-016252 · rdgdoc.xml · nonDerivative · entry 3 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,503 F2 · price: Reflects the weighted average price of 1,486 shares of common stock of Proto Labs, Inc. sold by the reporting person on August 24, 2018 with sale prices ranging from $146.10 to $146.65 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 24, 2018 Filed Aug 28, 2018 20:23 UTC |
WAY JOHNChief Financial Officer
|
SaleCommon Stock | 2,426 | $145.51 | $353,004.83 |
DisclosureSEC source: 0001437749-18-016252 · rdgdoc.xml · nonDerivative · entry 2 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,989 F1 · price: Reflects the weighted average price of 2,426 shares of common stock of Proto Labs, Inc. sold by the reporting person on August 24, 2018 with sale prices ranging from $145.00 to $145.95 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 24, 2018 Filed Aug 28, 2018 20:23 UTC |
WAY JOHNChief Financial Officer
|
Exercise / conversionCommon Stock | 3,912 | $62.90 | $246,064.80 |
DisclosureSEC source: 0001437749-18-016252 · rdgdoc.xml · nonDerivative · entry 1 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,415 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2018 Filed Aug 27, 2018 21:04 UTC |
Bodor RobertVP/General Manager-Americas
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $67.15 | $0.00 |
DisclosureSEC source: 0001437749-18-016197 · rdgdoc.xml · derivative · entry 3 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,998 Underlying: Common Stock · 3,000 shares Expires 2025-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2018. F3 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on February 13, 2016. Read SEC document |
| August 23, 2018 Filed Aug 27, 2018 21:04 UTC |
Bodor RobertVP/General Manager-Americas
|
SaleCommon Stock | 3,000 | $145.00 | $435,000.00 |
DisclosureSEC source: 0001437749-18-016197 · rdgdoc.xml · nonDerivative · entry 2 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,755 F2 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2018. Read SEC document |
| August 23, 2018 Filed Aug 27, 2018 21:04 UTC |
Bodor RobertVP/General Manager-Americas
|
Exercise / conversionCommon Stock | 3,000 | $67.15 | $201,450.00 |
DisclosureSEC source: 0001437749-18-016197 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2018. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 19:49 UTC |
Gawlick RainerDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 800 | $0.00 Strike: $5.56 | $0.00 |
DisclosureSEC source: 0001437749-18-014297 · rdgdoc.xml · derivative · entry 2 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,300 Underlying: Common Stock · 800 shares Expires 2019-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 19:49 UTC |
Gawlick RainerDirector
|
Exercise / conversionCommon Stock | 800 | $5.56 | $4,448.00 |
DisclosureSEC source: 0001437749-18-014297 · rdgdoc.xml · nonDerivative · entry 1 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 20:58 UTC |
Gawlick RainerDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 800 | $0.00 Strike: $5.56 | $0.00 |
DisclosureSEC source: 0001437749-18-014021 · rdgdoc.xml · derivative · entry 2 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,100 Underlying: Common Stock · 800 shares Expires 2019-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 20:58 UTC |
Gawlick RainerDirector
|
Exercise / conversionCommon Stock | 800 | $5.56 | $4,448.00 |
DisclosureSEC source: 0001437749-18-014021 · rdgdoc.xml · nonDerivative · entry 1 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,889 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 20:45 UTC |
Bodor RobertVP/General Manager-Americas
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,997 | $0.00 Strike: $67.15 | $0.00 |
DisclosureSEC source: 0001437749-18-012074 · rdgdoc.xml · derivative · entry 3 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,998 Underlying: Common Stock · 2,997 shares Expires 2025-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on February 13, 2016. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 20:45 UTC |
Bodor RobertVP/General Manager-Americas
|
SaleCommon Stock | 2,997 | $135.10 | $404,904.29 |
DisclosureSEC source: 0001437749-18-012074 · rdgdoc.xml · nonDerivative · entry 2 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,755 F1 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2017. F2 · price: Reflects the weighted average price of 2,997 shares of common stock of Proto Labs, Inc. sold by the reporting person on June 15, 2018 with sale prices ranging from $135.00 to $135.55 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 20:45 UTC |
Bodor RobertVP/General Manager-Americas
|
Exercise / conversionCommon Stock | 2,997 | $67.15 | $201,248.55 |
DisclosureSEC source: 0001437749-18-012074 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 20:47 UTC |
Goodman John BDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 536 | $0.00 Strike: $70.00 | $0.00 |
DisclosureSEC source: 0001437749-18-012020 · rdgdoc.xml · derivative · entry 6 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 536 Underlying: Common Stock · 536 shares Expires 2025-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 20:47 UTC |
Goodman John BDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 577 | $0.00 Strike: $62.68 | $0.00 |
DisclosureSEC source: 0001437749-18-012020 · rdgdoc.xml · derivative · entry 5 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 577 Underlying: Common Stock · 577 shares Expires 2024-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 20:47 UTC |
Goodman John BDirector
|
SaleCommon Stock | 400 | $130.85 | $52,340.00 |
DisclosureSEC source: 0001437749-18-012020 · rdgdoc.xml · nonDerivative · entry 4 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,078 F2 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 20:47 UTC |
Goodman John BDirector
|
SaleCommon Stock | 713 | $131.86 | $94,019.53 |
DisclosureSEC source: 0001437749-18-012020 · rdgdoc.xml · nonDerivative · entry 3 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,478 F2 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. F3 · price: Reflects the weighted average price of 713 shares of common stock of Proto Labs, Inc. sold by the reporting person on June 14, 2018 with sale prices ranging from $131.50 to $132.15 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 20:47 UTC |
Goodman John BDirector
|
Exercise / conversionCommon Stock | 536 | $70.00 | $37,520.00 |
DisclosureSEC source: 0001437749-18-012020 · rdgdoc.xml · nonDerivative · entry 2 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,191 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 20:47 UTC |
Goodman John BDirector
|
Exercise / conversionCommon Stock | 577 | $62.68 | $36,166.36 |
DisclosureSEC source: 0001437749-18-012020 · rdgdoc.xml · nonDerivative · entry 1 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,655 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 20:32 UTC |
Bodor RobertVP/General Manager-Americas
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $78.59 | $0.00 |
DisclosureSEC source: 0001437749-18-011837 · rdgdoc.xml · derivative · entry 3 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,160 Underlying: Common Stock · 3,000 shares Expires 2024-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on February 13, 2015. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 20:32 UTC |
Bodor RobertVP/General Manager-Americas
|
SaleCommon Stock | 3,000 | $130.00 | $390,011.70 |
DisclosureSEC source: 0001437749-18-011837 · rdgdoc.xml · nonDerivative · entry 2 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,755 F1 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2017. F2 · price: Reflects the weighted average price of 3,000 shares of common stock of Proto Labs, Inc. sold by the reporting person on June 12, 2018 with sale prices ranging from $130.00 to $130.10 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 20:32 UTC |
Bodor RobertVP/General Manager-Americas
|
Exercise / conversionCommon Stock | 3,000 | $78.59 | $235,770.00 |
DisclosureSEC source: 0001437749-18-011837 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 19:30 UTC |
WEHRWEIN SVENDirector
|
SaleCommon Stock | 1,000 | $125.00 | $125,000.00 |
DisclosureSEC source: 0001437749-18-011076 · rdgdoc.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,878 Read SEC document |
| May 16, 2018 Filed May 18, 2018 21:06 UTC |
Black Archie C.Director
|
GrantCommon Stock | 1,064 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-010380 · rdgdoc.xml · nonDerivative · entry 1 Black Archie C. · CIK 0001489095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,801 F1 · shares: The deferred stock units vest in full on May 16, 2019, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 16, 2018 Filed May 18, 2018 21:05 UTC |
Chand SujeetDirector
|
GrantCommon Stock | 1,064 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-010378 · rdgdoc.xml · nonDerivative · entry 1 Chand Sujeet · CIK 0001388884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,236 F1 · shares: The deferred stock units vest in full on May 16, 2019, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 16, 2018 Filed May 18, 2018 21:02 UTC |
Gawlick RainerDirector
|
GrantCommon Stock | 1,064 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-010375 · rdgdoc.xml · nonDerivative · entry 1 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,089 F1 · shares: The deferred stock units vest in full on May 16, 2019, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 16, 2018 Filed May 18, 2018 20:59 UTC |
Goodman John BDirector
|
GrantCommon Stock | 1,064 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-010373 · rdgdoc.xml · nonDerivative · entry 1 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,078 F1 · shares: The deferred stock units vest in full on May 16, 2019, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. F2 · balance_after: The reporting person's Form 4 filed on October 5, 2015 inadvertently understated the reporting person's direct holdings by 500 shares. Read SEC document |
| May 16, 2018 Filed May 18, 2018 20:58 UTC |
WEHRWEIN SVENDirector
|
GrantCommon Stock | 1,064 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-010370 · rdgdoc.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,878 F1 · shares: The deferred stock units vest in full on May 16, 2019, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 16, 2018 Filed May 18, 2018 20:45 UTC |
KRANTZ DONALD GDirector
|
GrantCommon Stock | 1,064 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-010367 · rdgdoc.xml · nonDerivative · entry 1 KRANTZ DONALD G · CIK 0001183159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,236 F1 · shares: The restricted stock units vest in full on the earlier of May 16, 2019 or the date of the Company's 2019 annual meeting of shareholders. Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 20:32 UTC |
Gawlick RainerDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 800 | $0.00 Strike: $5.56 | $0.00 |
DisclosureSEC source: 0001437749-18-007843 · rdgdoc.xml · derivative · entry 2 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,900 Underlying: Common Stock · 800 shares Expires 2019-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 20:32 UTC |
Gawlick RainerDirector
|
Exercise / conversionCommon Stock | 800 | $5.56 | $4,448.00 |
DisclosureSEC source: 0001437749-18-007843 · rdgdoc.xml · nonDerivative · entry 1 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,025 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 11, 2018 Filed Apr 13, 2018 20:26 UTC |
Gawlick RainerDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 800 | $0.00 Strike: $5.56 | $0.00 |
DisclosureSEC source: 0001437749-18-006861 · rdgdoc.xml · derivative · entry 2 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,700 Underlying: Common Stock · 800 shares Expires 2019-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| April 11, 2018 Filed Apr 13, 2018 20:26 UTC |
Gawlick RainerDirector
|
Exercise / conversionCommon Stock | 800 | $5.56 | $4,448.00 |
DisclosureSEC source: 0001437749-18-006861 · rdgdoc.xml · nonDerivative · entry 1 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 21:19 UTC |
Goodman John BDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 537 | $0.00 Strike: $70.00 | $0.00 |
DisclosureSEC source: 0001437749-18-004900 · rdgdoc.xml · derivative · entry 5 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,072 Underlying: Common Stock · 537 shares Expires 2025-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 21:19 UTC |
Goodman John BDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 577 | $0.00 Strike: $62.68 | $0.00 |
DisclosureSEC source: 0001437749-18-004900 · rdgdoc.xml · derivative · entry 4 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,154 Underlying: Common Stock · 577 shares Expires 2024-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 21:19 UTC |
Goodman John BDirector
|
SaleCommon Stock | 1,114 | $122.71 | $136,700.05 |
DisclosureSEC source: 0001437749-18-004900 · rdgdoc.xml · nonDerivative · entry 3 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,514 F2 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. F3 · price: Reflects the weighted average price of 1,114 shares of common stock of Proto Labs, Inc. sold by the reporting person on March 14, 2018 with sale prices ranging from $122.50 to $123.00 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 21:19 UTC |
Goodman John BDirector
|
Exercise / conversionCommon Stock | 537 | $70.00 | $37,590.00 |
DisclosureSEC source: 0001437749-18-004900 · rdgdoc.xml · nonDerivative · entry 2 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,628 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 21:19 UTC |
Goodman John BDirector
|
Exercise / conversionCommon Stock | 577 | $62.68 | $36,166.36 |
DisclosureSEC source: 0001437749-18-004900 · rdgdoc.xml · nonDerivative · entry 1 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,091 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. Read SEC document |
| February 14, 2018 Filed Feb 16, 2018 21:13 UTC |
WEHRWEIN SVENDirector
|
SaleCommon Stock | 2,000 | $107.00 | $214,000.00 |
DisclosureSEC source: 0001437749-18-002781 · rdgdoc.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,814 Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 00:49 UTC |
Bodor RobertVP/General Manager-Americas
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,891 | $0.00 Strike: $57.88 | $0.00 |
DisclosureSEC source: 0001437749-18-002616 · rdgdoc.xml · derivative · entry 5 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,673 Underlying: Common Stock · 1,891 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on February 13, 2017. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 00:49 UTC |
Bodor RobertVP/General Manager-Americas
|
SaleCommon Stock | 1,891 | $106.00 | $200,454.70 |
DisclosureSEC source: 0001437749-18-002616 · rdgdoc.xml · nonDerivative · entry 3 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,755 F3 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2017. F4 · price: Reflects the weighted average price of 1,891 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 13, 2018 with sale prices ranging from $106.00 to $106.03 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 00:49 UTC |
Bodor RobertVP/General Manager-Americas
|
Exercise / conversionCommon Stock | 1,891 | $57.88 | $109,451.08 |
DisclosureSEC source: 0001437749-18-002616 · rdgdoc.xml · nonDerivative · entry 2 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2018 Filed Feb 16, 2018 21:25 UTC |
HOLT VICTORIA MDirector · President and CEO
|
Tax withholdingCommon Stock | 3,361 | $106.45 | $357,778.45 |
DisclosureSEC source: 0001437749-18-002790 · rdgdoc.xml · nonDerivative · entry 1 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,874 Read SEC document |
| February 13, 2018 Filed Feb 16, 2018 21:23 UTC |
Baker Arthur R. IIIChief Technology Officer
|
Tax withholdingCommon Stock | 394 | $106.45 | $41,941.30 |
DisclosureSEC source: 0001437749-18-002789 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,820 Read SEC document |
| February 13, 2018 Filed Feb 16, 2018 22:04 UTC |
FEIN DAVID MChief Revenue Officer
|
Tax withholdingCommon Stock | 508 | $106.45 | $54,076.60 |
DisclosureSEC source: 0001437749-18-002805 · rdgdoc.xml · nonDerivative · entry 1 FEIN DAVID M · CIK 0001626274 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,339 Read SEC document |
| February 13, 2018 Filed Feb 16, 2018 21:14 UTC |
WAY JOHNChief Financial Officer
|
Tax withholdingCommon Stock | 1,148 | $106.45 | $122,204.60 |
DisclosureSEC source: 0001437749-18-002784 · rdgdoc.xml · nonDerivative · entry 1 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,717 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.